Adewole S. Adamson
Podcast Host at JAMA Dermatology Author Interviews (Podcast)
Web Editor at JAMA (The Journal of the American Medical Association)
Dermatologist | Health Services Researcher | Alum: @Morehouse @HarvardMed @MIT_HST @Kennedy_School | A naive EBM aficionado| Cancer researcher | Melanoma expert
Articles
-
1 month ago |
dermatologytimes.com | Emma Andrus |Adewole S. Adamson
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, presented a session titled, "The 2025 Debates: Controversies in Dermatology," at the 2025 American Academy of Dermatology (AAD) Annual Meeting.
-
1 month ago |
dermatologytimes.com | Emma Andrus |Adewole S. Adamson
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, presented a session titled, "Approach to Melanoma Diagnosis" at the 2025 American Academy of Dermatology (AAD) Annual Meeting. The session also tackled the increasingly significant topic of melanoma overdiagnosis, which has garnered heightened attention in recent years.
-
1 month ago |
dermatologytimes.com | Emma Andrus |Adewole S. Adamson
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, is preparing for this week's 2025 American Academy of Dermatology (AAD) Annual Meeting, which will take place from March 7-11 in Orlando, Florida. At the meeting, Adamson will be participating in 2 sessions: "Approach to Melanoma Diagnosis" and "The 2025 Debates: Controversies in Dermatology," both of which will take place on Friday, March 7.
-
Aug 28, 2024 |
jamanetwork.com | Ayisha N. Mahama |Courtney Haller |Adewole S. Adamson |LIVESTRONG Cancer Institutes
Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?—Reply Experience and Fear of Cancer Recurrence Among Survivors of Localized Melanoma Ayisha N. Mahama, MD, MPH; Courtney N. Haller, MD; Jocelyn Labrada, BA; Christie I. Idiong, MS; Alex B. Haynes, MD, MPH; Elizabeth A. Jacobs, MD,, MAPP; Joel Tsevat, MD, MPH; Michael P. Pignone, MD, MPH; Adewole S.
-
Aug 21, 2024 |
statnews.com | Adewole S. Adamson |Vishal Patel |H. Gilbert Welch
For years, Black Americans have been more likely to die of cancer than white Americans. There is a widespread belief that cancer screening — tests to detect hidden cancer — can reduce this Black-white disparity. While it is important to be attentive to racial disparities in health and health care, the belief in screening is misguided. More cancer screening primarily serves the interests of the health care system, not those of Black Americans.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 7K
- Tweets
- 17K
- DMs Open
- Yes
Industry right now waiting to go on a hiring spree. https://t.co/G8UYbpTFpJ
Turnover is routine in Washington, but there's been a flood of health worker departures under the Trump administration. STAT is keeping track of all the senior FDA officials who have left the agency.
I'm assuming by she is referring to cutaneous SCC here and if so this is a pretty outlandish claim that can't possibly be true. Also, I'm glad that the overwhelming evidence suggesting melanoma overdiagnosis is now just "hype"...lol. https://t.co/BSxFIcsjSV
Not the AAD promoting this nonsense based on a garbage study. The rationale for this product is basically this: a tropical fern plant produces a chemical that protects it from the sun...so if you just eat extracts from the plant it will act like sunscreen. #magicalthinking https://t.co/MT0qiFnYpq
